AVM v1, released 02-OCT-22

A manually curated database of aerosol-transmitted virus mutations, human diseases, and drugs

Mutation detail:


Mutation site N265S
Virus Influenzavirus A H1N1
Mutation level Amino acid Level
Gene/protein/region type PB2
Gene ID 23308131
Country -
Mutation type nonsynonymous mutation
Genotype/subtype/clade -
Sample cell line
Variants -
Viral reference sequence FJ966079.1
Drug/antibody/vaccine -
Transmissibility -
Transmission mechanism -
Pathogenicity -
Pathogenicity mechanism -
Immune escape mutation -
Immune escape mechanism -
RT-PCR primers probes -

Protein detail:


Protein name Polymerase PB2
Uniprot protein ID C3W5X5
Protein length 759 amino acids
Protein description PB2 plays an essential role in transcription initiation and cap-stealing mechanism, in which cellular capped pre-mRNAs are used to generate primers for viral transcription. Recognizes and binds the 7-methylguanosine-containing cap of the target pre-RNA which is subsequently cleaved after 10-13 nucleotides by the viral protein PA. Plays a role in the initiation of the viral genome replication and modulates the activity of the ribonucleoprotein (RNP) complex.

Literature information:


Pubmed ID 25122786
Clinical information No
Disease -
Published year 2014
Journal JOURNAL OF VIROLOGY
Title The Temperature-Sensitive and Attenuation Phenotypes Conferred by Mutations in the Influenza Virus PB2, PB1, and NP Genes Are Influenced by the Species of Origin of the PB2 Gene in Reassortant Viruses Derived from Influenza A/California/07/2009 and A/WSN/
Author Andrew J. Broadbent,Celia P. Santos,Rachel A. Godbout,Kanta Subbarao
Evidence The following mutations were made in the WSN, CA07, and VN04 plasmids: PB1-K391E, -E581G, and -A661T and PB2-N265S. In addition, a D34G mutation was made in the WSN NP plasmid and an S34G mutation was made in the VN04 NP plasmid. The CA07 NP plasmid already contained a glycine at amino acid position 34, so it was not necessary to mutate the plasmid.